Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by Bunge on Feb 09, 2021 9:55am

$2

We should be $2 RIGHT NOW.

User image

EOM
Comment by ScienceFirst on Feb 09, 2021 9:59am
And why 2$ Bunge?  Why not 12.58$ while you're there.  It's been 7 years that's all you've been focused on is the share price.  Why don't you move your a%% and do some digging on the R&D side like many others.  Do your part, lazzy boy. 
Comment by ScienceFirst on Feb 09, 2021 10:07am
Decline my R&D offer Lazy Bunge.  We saw what your libertarian view delivered on the "science" side;  HCQ Kool-Aid with or without zinc, with or without 10W30!!! ... lollll Go back to your lazy boy and have a nap.  Go dream thinking that money will make you more credibile to the eyes of your fatrer-in-law! ... lolll
Comment by Toad09 on Feb 09, 2021 12:23pm
Well, I put a $12 sell in with max expiry date and quite quickly recieved a phone call saying I couldn't ask that much over the current price.  That was about 2yrs ago now.  Theralase rep right at the bank, idk?  crazy I think.   So much for an investor setting the price.
Comment by Bunge on Feb 09, 2021 2:24pm
I see Too Soon benny is at it again. Years of: 78 cents: Pump 60 cents: Pump 50 cents: Pump 40 cents: Pump 30 cents: Pump 20 cents: Pump 12 cents: You're all fools for thinking TLT would go up in price before 2030. Regurgitating way off-topic things too (libertarian Bunge lives rent free). Benny used to have .500 batting average for valuable posts. Last 3 or 4 years he's batting .000. ...more  
Comment by ScienceFirst on Feb 09, 2021 2:43pm
Bunge ... You forgot to mention that your GMR went to 0$. Weren't you the one that told us that your last success dated back to early 2000! Weren't you the one that took too much time to do his "dd" on HPQ, PYR, VPT? lolll You're the real loser Bunge.  No doubt.  You're alone in your category.  And you thought Keytruda was a threat! ... lolll
Comment by Bigkahuna57 on Feb 09, 2021 9:17pm
Science - stick to the investment and quit being a d!ck.  Good luck to all. Regards, BK
Comment by Bunge on Feb 10, 2021 11:50am
I would go back and document and hi-light years of his pronouncements and flipflops and ridicule to us TLT longs but alas, bencro, claridge, peer reviewed, science first, etc. had been banned so many times there's no history. 
Comment by ScienceFirst on Feb 10, 2021 10:20pm
Bungee ... I used the hi-light to help you understand the important things you couldn't understand when reading a post, given your low capacity of analysis.  Even there, you couldn't even understand that simple fact!  So funny!  It's like when you thought that Merck was a threat to us, when it was rather the total opposite!  Your "Hurry up guys" ...more  
Comment by ScienceFirst on Feb 09, 2021 2:49pm
Bungee the lazy ...  Weren't you the one that your family invested in TLT before it entered the oncology field? lolll You're the one that was telling us 4 years ago that TLT should have been valued at 1$-2$ when in fact, we didn't even have a rug manufacturer!  Not even a HC approval. Superficial one day, superficial every day, aren't you Bungee!  No wonder why you ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250